InvestorsHub Logo
Followers 1
Posts 237
Boards Moderated 0
Alias Born 12/21/2013

Re: john1045 post# 3337

Sunday, 01/12/2014 12:21:54 PM

Sunday, January 12, 2014 12:21:54 PM

Post# of 732730
Thanks for posting the Scancell article. It appears they are using DNA injected into the patient which then expresses antigens which are then taken up by dendritic cells. Quite a different approach than NWBO but very similar in that dendritic cells are the immune system target, but again different (and more like IMUC) in that they are using predetermined antigens. Will be interesting to follow their testing. They have found that some patients' tumors lose the targeted antigen expression, which makes sense. I had to think, gee, it's too bad they're not using NWBO's approach. They could just prepare a new batch of vaccine using lysate from the new tumor growth ( except there would probably already have been some of those DCs from the original prep anyway and the tumor would never have come back)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News